Serum vitamin A and beta-carotene levels in pregnant women infected with human immunodeficiency virus-1. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Serum vitamin A and beta-carotene levels in pregnant women infected with human immunodeficiency virus-1.

Obstet Gynecol. 1996 Apr;87(4):564-7. Unique Identifier : AIDSLINE MED/96179708
Phuapradit W; Chaturachinda K; Taneepanichskul S; Sirivarasry J; Khupulsup K; Lerdvuthisopon N; Department of Obstetrics and Gynecology, Faculty of Medicine,; Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.


Abstract: OBJECTIVE: To determine if low levels of serum vitamin A and beta-carotene are present in pregnant women with human immunodeficiency virus-1 (HIV-1) infection. METHODS: Serum concentrations of vitamin A and beta-carotene were measured in 74 pregnant women seropositive for HIV-1 infection (17 with CD4 count below 200 cells/microliter) and in 148 pregnant seronegative controls in the first trimester. Comparisons were made between groups stratified by CD4 count. RESULTS: Compared with controls, women with HIV-1 infection and CD4 count below 200 cells/microliter exhibited 37% lower mean serum vitamin A levels (0.820 versus 1.308 micromol/L, P < .001) and 37% lower mean serum beta-carotene levels (1.486 versus 2.362 micromol/L, P < .001). Mean maternal age, parity, gestational age, hemoglobin levels, and body mass index at entry into the study did not differ significantly between the control and HIV-1 infection groups. In addition, serum vitamin A levels correlated significantly with the percentage of CD4 lymphocytes (r = 0.589, P < .001), CD4 count (r = 0.772, P < .001), and CD4 to CD8 ratio (r = 0.593, P < .001). Serum beta-carotene levels correlated with the percentage of CD4 lymphocytes (r = 0.407, P < .001), CD4 count (r = 0.614, P < .001), and CD4 to CD8 ratio (r = 0.434, P < .001). CONCLUSION: Compared with levels in uninfected women, serum vitamin A and beta-carotene are decreased in HIV-1-infected pregnant women in the first trimester with CD4 counts lower than 200 cells/microliter. These micronutrient concentrations also correlate with CD4 count.
Keywords: Adult Body Mass Index Carotene/*BLOOD CD4 Lymphocyte Count CD4-CD8 Ratio Female Hemoglobins/ANALYSIS Human HIV Infections/*BLOOD *HIV-1 Maternal Age Parity Pregnancy Pregnancy Complications, Infectious/*BLOOD Pregnancy Trimester, First Support, Non-U.S. Gov't Vitamin A/*BLOOD JOURNAL ARTICLEKWDadultbodymassindexcarotene/KWDbloodcd4lymphocytecountcd4-cd8ratiofemalehemoglobins/analysishumanhivinfections/KWDbloodKWDhiv-1maternalageparitypregnancypregnancycomplications,infectious/KWDbloodpregnancytrimester,firstsupport,non-uKWDsKWDgov'tvitamina/KWDbloodjournalarticle
960730
M9670422

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .